Section 439.740 - Requirements for data and information included in report compiled by Department concerning price of essential diabetes drugsIn the report compiled by the Department pursuant to NRS 439B.650, as amended by section 14 of Senate Bill No. 380, chapter 547, Statutes of Nevada 2021, at page 3727, the Department will include:
1. Only aggregated data that does not disclose the identity of any drug, manufacturer, wholesaler or pharmacy benefit manager; and2. In addition to the information required by NRS 439B.650, as amended by section 14 of Senate Bill No. 380, chapter 547, Statutes of Nevada 2021, at page 3727, a description of trends concerning the prices of prescription drugs that appear on the most current lists compiled by the Department pursuant to NRS 439B.630, as amended by section 10 of Senate Bill No. 380, chapter 547, Statutes of Nevada 2021, at page 3723, and an explanation of how those prices and trends may affect: (a) The prevalence and severity of diabetes in this State; and(b) The system of health care in this State.Nev. Admin. Code § 439.740
Added to NAC by Dep't of Health & Human Services by R042-18, eff. 5-31-2018; A by R121-20A, eff. 6/13/2022NRS 439B.685, as amended by section 16 of Senate Bill No. 380, chapter 547, Statutes of Nevada 2021, at page 3728